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Introduction {#s1}
============

Cardiovascular disease (CVD) is a leading cause of death worldwide, contributing to 17.7 million deaths in 2015 ([@c33]). Many epidemiological studies have shown that long-term exposure to particulate matter (PM) air pollution is associated with increased cardiovascular morbidity and mortality ([@c3]; [@c19]; [@c25]). The American Heart Association states a causal relationship between CVD and PM, particularly PM with an aerodynamic diameter $< 2.5\;\mu m$ (${PM}_{2.5}$), which can penetrate deep into the lungs ([@c3]). However, the underlying mechanisms of the relationship between ${PM}_{2.5}$ and CVD remain uncertain. One potential mechanism by which PM may contribute to CVD development is through its effects on blood pressure. PM exposure can lead to imbalances in the autonomic nervous system and to local and systemic inflammation and oxidative stress, which result in elevated blood pressure ([@c3]). High blood pressure is a well-established determinant of atherosclerosis, which is the underlying pathology of most CVDs ([@c2]).

An increasing number of studies have shown that short-term exposure to PM is associated with increases in blood pressure ([@c8]; [@c12]; [@c13]; [@c15]; [@c20]; [@c37]). However, evidence on the long-term effects of PM on blood pressure is scarce and inconsistent. Some studies have reported that long-term exposure to PM and black carbon is associated with increased blood pressure ([@c5]; [@c7]; [@c9]; [@c14]; [@c16]; [@c26]), but two large studies in Europe ([@c17]) and the United States ([@c27]) did not support a significant association. Studies on the associations between PM and incident hypertension are even scarcer, and the results are similarly inconsistent ([@c6]; [@c10], [@c11]; [@c39]).

Large-scale prospective cohort studies may provide more stable results and allow more precise estimates. Furthermore, although most previous studies were conducted in North America and Europe, little evidence is available from other regions, such as East Asia, where air pollution is often more serious. To our knowledge, only three studies have investigated the association between PM air pollution and blood pressure in this region, and all of these studies are of cross-sectional design ([@c7]; [@c9]; [@c14]). However, hypertension causes a heavy disease burden in Asian countries, with a population-attributable fraction of 60% for CVD ([@c23]). We therefore used a satellite-based spatiotemporal model to estimate PM exposure and investigated the effects of long-term exposure to fine particulate matter (${PM}_{2.5}$) on blood pressure and incident hypertension in a large Taiwanese cohort.

Methods {#s2}
=======

Study Participants {#s2.1}
------------------

We studied participants from a large cohort in Taiwan, which has been documented elsewhere ([@c24]; [@c32]; [@c38]). In brief, $> 500,000$ residents from all over Taiwan participated in a standard medical examination program provided by a private firm (MJ Health Management Institution, Taipei, Taiwan) from 1996 to 2014. The participants received a series of medical examinations including general physical examinations, anthropometric measurements, and biochemical tests of blood and urine. A standard self-administered questionnaire was also used to collect demographic and socioeconomic information, lifestyle indicators, and medical history. All participants gave written informed consent before their participation. Ethical approval was obtained from the Joint Chinese University of Hong Kong--New Territories East Cluster Clinical Research Ethics Committee.

In this study, we included participants $\geq 18\; y$ old who had joined the program between 2001 and 2014, when satellite data used for ${PM}_{2.5}$ exposure assessment were available. During this period, blood pressure was available for 424,061 participants. A total of 62,501 participants were excluded because of missing information on key potential confounders (57,412 cases) or on ${PM}_{2.5}$ exposure due to missing address information (5,069 cases) or because they had a systolic blood pressure (SBP) $\geq 250\,\text{mmHg}$ or a diastolic blood pressure (DBP) $\geq 150\,\text{mmHg}$ (20 cases), which were likely due to measurement error. Finally, 361,560 participants were included in the data analysis to investigate the effects of ${PM}_{2.5}$ on blood pressure. A total of 148,513 participants (148,513 of 361,560; 41.1%) had at least two visits (medical examinations) during the study period. Of these, 125,913 participants (84.8%) without hypertension (defined as having $\text{SBP} \geq 140\,\text{mmHg}$ or $\text{DBP} \geq 90\,\text{mmHg}$, or having self-reported physician-diagnosed hypertension) at their first visit were followed up and included in the analysis of the effects of ${PM}_{2.5}$ on the development of hypertension.

Air Pollution Exposure Assessment {#s2.2}
---------------------------------

A satellite-based spatiotemporal model was used for ${PM}_{2.5}$ exposure assessment; the details of this model have been described in our previous study ([@c38]). Briefly, we developed the model to retrieve ground-level ${PM}_{2.5}$ concentrations at a high resolution ($1\;{km} \times 1\;{km}$) based on aerosol optical depth (AOD) data, which were derived from the spectral data from the two Moderate Resolution Imaging Spectroradiometer (MODIS) instruments aboard the U.S. National Aeronautics and Space Administration's (NASA's) Terra and Aqua satellites. The model was validated using ground-measured ${PM}_{2.5}$ data from $> 70$ monitoring stations in Taiwan. The correlation coefficients between the satellite-retrieved and ground-measured yearly average ${PM}_{2.5}$ concentrations ranged from 0.79 to 0.83, and the mean percentage errors were approximately 20% ([@c38]).

Each participant's address (either residence or company) was geocoded into latitude and longitude data, and then address-specific yearly average ${PM}_{2.5}$ concentrations were calculated. Afterwards, the 2-y average concentration was calculated (based on the concentrations from the year of the medical examination and the year before the medical examination) as an indicator of long-term exposure to ambient ${PM}_{2.5}$ air pollution.

Health Examination {#s2.3}
------------------

The participants visited the medical center in the morning. After a 10-min rest, SBP and DBP were measured with a computerized auto-mercury sphygmomanometer (CH-5000; Citizen) with the participant seated. If the SBP was $\geq 140\,\text{mmHg}$ or the DBP was $\geq 90\,\text{mmHg}$, a second measurement was obtained after 10 min, and the records from the second measurement were used for data analysis. The pulse pressure (PP) was computed as the difference between the SBP and the DBP. The weight and barefoot height were measured, and the body mass index (BMI) was calculated as the weight (kg) divided by the square of the height (m). An overnight fasting venous blood sample was taken to measure blood lipids (total cholesterol, triglycerides, and high-density lipoprotein cholesterol) and plasma glucose using an auto-analyzer (model 7150; Hitachi). Blood samples were analyzed at the central laboratory of MJ Health Screening Center by trained technicians. A standard self-administered questionnaire survey was also conducted to collect information on demographic and socioeconomic factors, lifestyle, and disease history. All of the examination procedures were approved according to International Organization for Standardization (ISO) 9001, and the relevant quality-control measures can be found in the technical report of the MJ Health Research Foundation ([@c24]).

For the 125,913 initially nonhypertensive participants, the presence or absence of incident hypertension was identified in their subsequent visits and was defined as an SBP $\geq 140\,\text{mmHg}$ or a DBP $\geq 90\,\text{mmHg}$ or as a self-report of newly physician-diagnosed hypertension after the first visit. The number of visits ranged from 2 to 18 with a mean of 3.4 \[standard deviation (SD): 2.0\]. The censoring date was the first occurrence of hypertension or the last visit if hypertension did not occur.

Statistical Analysis {#s2.4}
--------------------

Statistical analyses were performed using R (version 3.2.3; R Core Team). A two-tailed *p*-value $< 0.05$ was considered statistically significant.

### $PM_{2.5}$ Air pollution and blood pressure. {#s2.4.1}

We used the multivariable linear regression model to conduct a cross-sectional data analysis of the associations between ${PM}_{2.5}$ exposure and blood pressure using the baseline (first-visit) data of the 361,560 participants. The following covariates were introduced into the models: age (y), sex, education level \[less than high school ($< 10\; y$), high school (10--12 y), college or university (13--16 y), or postgraduate ($> 16\; y$)\], smoking status (never, former, or current), alcohol drinking (less than once per week, one to three times per week, or more than three times per week), leisure-time physical activity ($< 1\; h/{wk}$, $1\text{−}2\; h/{wk}$, or $> 2\; h/{wk}$), occupational exposure to dust or organic solvents in the workplace (yes or no), season (calendar season), BMI, hypertension (defined above), diabetes (fasting blood glucose $\geq 126\;{mg}/\text{dL}$ or self-reported physician-diagnosed diabetes), hyperlipidemia (total cholesterol $\geq 240\;{mg}/\text{dL}$, triglycerides $\geq 200\;{mg}/\text{dL}$, or high-density lipoprotein cholesterol $< 40\;{mg}/\text{dL}$), any self-reported CVD or stroke (yes or no), and any self-reported form of cancer (yes or no). The participants were categorized into four groups based on the ${PM}_{2.5}$ quartiles. When ${PM}_{2.5}$ was treated as a continuous variable, effect estimates were calculated as changes in blood pressure for each $10{- \mu g/m}^{3}$ increment in the 2-y average ${PM}_{2.5}$ concentration.

We examined whether the association between blood pressure and ${PM}_{2.5}$ exposure was modified by age ($< 65\; y$ and $\geq 65\; y$), sex (men and women), education level (high school or lower, and above high school), smoking (never and ever smoker), hypertension (hypertensive and nonhypertensive), diabetes (diabetic and nondiabetic), and obesity ($\text{BMI} < 25{\,{kg}/m}^{2}$ and $\text{BMI} \geq 25{\,{kg}/m}^{2}$) ([@c31]). Each potential modifier was examined in separate models by adding a multiplicative interaction term for ${PM}_{2.5}\,\left( \text{continuous}\,\text{variable} \right)\, \times \, a\,\text{potential}\,\text{modifier}\,\left( \text{dichotomous}\,\text{variable} \right)$, and *p*-values for the product terms were calculated. Subgroup analyses stratified by these factors were also performed.

### $\mathbf{P}\mathbf{M}_{2.5}$ Air pollution and incident hypertension. {#s2.4.2}

Among the 125,913 nonhypertensive participants with follow-up, Cox proportional hazard regression was used to calculate the hazard ratio (HR) for incident hypertension associated with ${PM}_{2.5}$ exposure after adjusting for age, sex, educational level, smoking, alcohol drinking, physical activity, occupational exposure, season, BMI, diabetes, hyperlipidemia, self-reported CVD or stroke, and cancer. Effect modification by age, sex, educational level, smoking, diabetes, and obesity was also assessed.

Sensitivity Analysis {#s2.5}
--------------------

We also performed a series of sensitivity analyses. For analysis on ${PM}_{2.5}$ and blood pressure, *a*) we excluded participants who used their company address rather than their home address, and *b*) we restricted the study participants to those who were free of obesity, hypertension, diabetes, hyperlipidemia, cardiovascular disease, stroke, and cancer to minimize the influence of comorbidities. For analysis of ${PM}_{2.5}$ and incident hypertension, we excluded participants with $< 2\; y$ of follow-up to eliminate the potential influence of short follow-up because hypertension development is generally a chronic process.

Results {#s3}
=======

The general characteristics of the study participants are summarized in [Table 1](#t1){ref-type="table"}. The mean age was $39.9\; y$ \[standard deviation (SD): 13.0\], and men were slightly in the minority (48.5%). Most study participants were well-educated, had never been smokers, and did not use alcohol. Generally, the participants selected for incident hypertension analysis were healthier than the overall cohort, with lower SBP, DBP, and PP values and lower prevalence of diabetes, hyperlipidemia, self-reported CVD or stroke, and self-reported cancer. The mean follow-up duration was 4.5 y (SD: 3.1), and 15,587 incident hypertension cases were identified during the study period.

###### 

Baseline characteristics of study participants.

Table 1 lists characteristics in the first column; the corresponding values for overall cohort and non-hypertensive participants with follow-up are listed in the other columns.

  Characteristics                                  Overall cohort    Nonhypertensive participants with follow-up
  ------------------------------------------------ ----------------- ---------------------------------------------
  Participants (*n*)                               361,560           125,913
  Age (y)                                          39.9 (13.0)       37.6 (10.9)
  Male                                             175,222 (48.5%)   60,758 (48.3%)
  Educational level                                                   
    Lower than high school                         58,629 (16.2%)    13,245 (10.5%)
    High school                                    73,261 (20.3%)    25,279 (20.1%)
    College or university                          186,963 (51.7%)   71,389 (56.7%)
    Postgraduate                                   42,707 (11.8%)    16,000 (12.7%)
  Cigarette smoking                                                   
    Never                                          267,562 (74.0%)   95,022 (75.5%)
    Former                                         20,859 (5.8%)     6,354 (5.0%)
    Current                                        73,139 (20.2%)    24,537 (19.5%)
  Alcohol drinking                                                    
    $< 1\,\text{time}/{wk}$                        310,460 (85.9%)   109,420 (86.9%)
    1--3 times/wk                                  339,26 (9.4%)     11,570 (9.2%)
    $> 3\,\text{times}/{wk}$                       17,174 (4.7%)     4,923 (3.9%)
  Physical activity                                                   
    $< 1\; h/{wk}$                                 163,031 (45.1%)   58,944 (46.8%)
    1--2 h/wk                                      114,015 (31.5%)   38,815 (30.8%)
    $> 2\; h/{wk}$                                 84,514 (23.4%)    28,154 (22.4%)
  Occupational exposure                                               
    Dust                                           13,493 (3.7%)     4,644 (3.7%)
    Organic solvent                                17,733 (4.9%)     6,508 (5.2%)
  Body mass index (${{kg}/m}^{2}$)                 23.0 (3.7)        22.6 (3.4)
  Systolic blood pressure ($\text{mmHg}$)          117.9 (17.6)      113.1 (12.7)
  Diastolic blood pressure ($\text{mmHg}$)         70.9 (11.4)       67.8 (8.9)
  Pulse pressure ($\text{mmHg}$)                   47.0 (11.7)       45.3 (9.6)
  Hypertension                                     56,716 (15.7%)    NA
  Diabetes                                         16,652 (4.6%)     2,790 (2.2%)
  Hyperlipidemia                                   83,194 (23.0%)    25,707 (20.4%)
  Self-reported cancer                             4,226 (1.2%)      1,174 (0.9%)
  Self-reported cardiovascular disease or stroke   10,891 (3.0%)     2,214 (1.8%)

Note: Data are the mean (standard deviation) for continuous variables and number (percentage) for categorical variables. NA, not available.

[Figure 1](#f1){ref-type="fig"} presents the locations of the study participants. The distribution of the 2-y average ${PM}_{2.5}$ concentrations of all participants is presented by year in [Table 2](#t2){ref-type="table"}. The spatial distribution of ${PM}_{2.5}$ over Taiwan was generally stable during the study period. No apparent upward or downward trends in ${PM}_{2.5}$ were observed over the study period. The mean concentration of the overall cohort was 26.5 (SD: 7.6) ${\mu g/m}^{3}$, and the median was $23.9\,{\mu g/m}^{3}$ \[interquartile range (IQR): 6.9\]. The participants who were followed up for incident hypertension analysis had ${PM}_{2.5}$ levels similar to those of the overall cohort.

![Location map of the study participants. (*A*) 361,560 participants in blood pressure--${PM}_{2.5}$ analysis. (*B*) 125,913 participants in incident hypertension--${PM}_{2.5}$ analysis. Circles represent the locations of the study participants.](EHP2466_f1){#f1}

###### 

Distribution of 2-y average ${PM}_{2.5}$ concentrations (${\mu g/m}^{3}$) at baseline.

Table 2 lists years in the first column; the corresponding N values, mean (SD), 25th percentile, 50th percentile, 75th percentile for overall cohort and non-hypertensive participants with follow-up are listed in the other columns.

  Year                                                                                    Overall cohort
  ------ --------- ------------ ------ ------ ------ --------- ------------ ------ ------ ----------------
  2001   56,688    25.0 (7.4)   19.9   22.5   28.7   27,605    24.8 (7.4)   19.9   22.3   25.6
  2002   42,830    26.6 (8.3)   21.0   23.5   35.0   18,107    26.5 (8.3)   20.8   23.4   34.4
  2003   29,159    28.8 (8.4)   23.0   25.8   36.0   11,178    28.8 (8.4)   23.1   25.8   36.0
  2004   28,942    29.9 (8.8)   23.7   26.5   38.6   11,544    29.9 (8.8)   23.6   26.5   38.9
  2005   28,282    27.4 (7.8)   22.2   24.5   29.8   10,653    27.4 (7.6)   22.3   24.8   30.9
  2006   26,989    26.9 (6.9)   22.5   24.6   27.7   9,512     26.9 (6.8)   22.5   24.8   27.5
  2007   26,882    26.8 (6.6)   22.6   24.9   27.6   8,863     26.8 (6.5)   22.7   25.0   27.4
  2008   23,516    26.8 (6.7)   22.6   24.7   27.4   7,567     26.8 (6.6)   22.6   24.8   27.3
  2009   18,930    27.2 (7.2)   22.5   24.9   30.0   6,125     27.7 (7.3)   22.7   25.3   31.4
  2010   20,471    25.9 (7.2)   21.5   23.3   26.7   6,077     26.3 (7.4)   21.6   23.6   29.6
  2011   18,484    25.5 (7.1)   20.8   23.1   26.2   4,944     25.7 (7.1)   21.0   23.4   26.2
  2012   20,696    24.4 (6.2)   20.3   22.8   25.3   3,123     24.3 (5.7)   20.9   22.9   25.2
  2013   15,366    23.7 (5.9)   19.8   22.2   25.5   615       23.8 (5.0)   20.7   22.9   25.3
  2014   4,325     24.4 (4.5)   21.2   24.1   26.1   ---       ---          ---    ---    ---
  All    361,560   26.5 (7.6)   21.6   23.9   28.5   125,913   26.7 (7.7)   21.6   24.0   28.9

Note: ---, the end year of the study period is 2014; therefore participants enrolled in 2014 had no follow-up and were not included in the incident analysis. SD, standard deviation.

Based on the crude model, participants with ${PM}_{2.5}$ values in the third and fourth quartiles had higher SBP than participants in the lowest quartile of ${PM}_{2.5}$, and those in the second, third, and fourth quartiles had higher PP than participants in the lowest quartile of ${PM}_{2.5}$ ([Table 3](#t3){ref-type="table"}). After fully adjusting for potential confounders (Adjusted Model 3), participants with ${PM}_{2.5}$ values in the second, third, and fourth quartiles had increased levels of SBP and PP compared with those who had 2-y average ${PM}_{2.5}$ values in the lowest quartile ([Table 3](#t3){ref-type="table"}). Participants with ${PM}_{2.5}$ in the fourth quartile had higher DBP, whereas those with ${PM}_{2.5}$ in the second and third quartiles had lower DBP, relative to those in the lowest quartile of ${PM}_{2.5}$ exposure. These results remained robust after adjusting for confounders ([Table 3](#t3){ref-type="table"}). When ${PM}_{2.5}$ was treated as a continuous variable, based on the fully adjusted model (Adjusted Model 3), each $10{- \mu g/m}^{3}$ increment was associated with increases of $0.45\,\text{mmHg}$ \[95% confidence interval (CI): 0.40, 0.50\] in SBP, $0.07\,\text{mmHg}$ (95% CI: 0.04, 0.11) in DBP, and $0.38\,\text{mmHg}$ (95% CI: 0.33, 0.42) in PP ([Table 3](#t3){ref-type="table"}).

###### 

Associations between long-term exposure to ${PM}_{2.5}$ and blood pressure in Taiwanese adults at baseline.

Table 3 lists PM sub 2.5 (n equals 361,560) in the first column; the corresponding coefficients (95 percent confidence intervals) and P values for the crude model, adjusted model 1, adjusted model 2, and adjusted model 3 are listed in the other columns.

  ${PM}_{2.5}$ ($n = 361,560$)                                                                                                                                                                           Crude model
  --------------------------------- ------------------------------- ----------- ------------------------------- ----------- ------------------------------- ----------- ------------------------------- -------------
  Systolic blood pressure                                                                                                                                                                                      
    1st Quartile                    Reference                           ---                Reference                ---                Reference                ---                Reference                 ---
    2nd Quartile                    $- 0.14$ ($- 0.30$, 0.02)          0.09            0.46 (0.32, 0.60)         $< 0.001$         0.46 (0.32, 0.61)         $< 0.001$         0.49 (0.38, 0.60)          $< 0.001$
    3rd Quartile                    0.28 (0.11, 0.44)                  0.001           0.89 (0.75,1.04)          $< 0.001$         0.90 (0.76, 1.05)         $< 0.001$         0.90 (0.79, 1.02)          $< 0.001$
    4th Quartile                    1.44 (1.28, 1.60)                $< 0.001$         1.01 (0.86, 1.15)         $< 0.001$         0.91 (0.77, 1.05)         $< 0.001$         0.85 (0.74, 0.97)          $< 0.001$
    Trend test                      ---                              $< 0.001$                ---                $< 0.001$                ---                $< 0.001$                ---                 $< 0.001$
    $10{- \mu g/m}^{3}$ increment   0.75 (0.68, 0.83)                $< 0.001$         0.52 (0.45, 0.58)         $< 0.001$         0.47 (0.40, 0.53)         $< 0.001$         0.45 (0.40, 0.50)          $< 0.001$
  Diastolic blood pressure                                                                                                                                                                                     
    1st Quartile                    Reference                           ---                Reference                ---                Reference                ---                Reference                 ---
    2nd Quartile                    $- 0.82$ ($- 0.92$, $- 0.71$)    $< 0.001$   $- 0.58$ ($- 0.67$, $- 0.48$)   $< 0.001$   $- 0.57$ ($- 0.66$, $- 0.48$)   $< 0.001$   $- 0.55$ ($- 0.63$, $- 0.47$)    $< 0.001$
    3rd Quartile                    $- 0.70$ ($- 0.81$, $- 0.60$)    $< 0.001$   $- 0.44$ ($- 0.53$, $- 0.34$)   $< 0.001$   $- 0.42$ ($- 0.52$, $- 0.33$)   $< 0.001$   $- 0.42$ ($- 0.50$, $- 0.34$)    $< 0.001$
    4th Quartile                    0.45 (0.35, 0.56)                $< 0.001$         0.25 (0.15, 0.34)         $< 0.001$         0.20 (0.11, 0.30)         $< 0.001$         0.17 (0.09, 0.24)          $< 0.001$
    Trend test                      ---                              $< 0.001$                ---                $< 0.001$                ---                $< 0.001$                ---                 $< 0.001$
    $10{- \mu g/m}^{3}$ increment   0.21 (0.16, 0.26)                $< 0.001$         0.11 (0.06, 0.15)         $< 0.001$         0.08 (0.04, 0.13)         $< 0.001$         0.07 (0.04, 0.11)          $< 0.001$
  Pulse pressure                                                                                                                                                                                               
    1st Quartile                    Reference                           ---                Reference                ---                Reference                ---                Reference                 ---
    2nd Quartile                    0.67 (0.57, 0.78)                $< 0.001$         1.04 (0.94, 1.14)         $< 0.001$         1.03 (0.93, 1.14)         $< 0.001$         1.04 (0.95, 1.14)          $< 0.001$
    3rd Quartile                    0.98 (0.87, 1.09)                $< 0.001$         1.33 (1.23, 1.43)         $< 0.001$         1.33 (1.22, 1.43)         $< 0.001$         1.33 (1.23, 1.42)          $< 0.001$
    4th Quartile                    0.99 (0.88, 1.10)                $< 0.001$         0.76 (0.66, 0.86)         $< 0.001$         0.71 (0.61, 0.81)         $< 0.001$         0.69 (0.59, 0.78)          $< 0.001$
    Trend test                      ---                              $< 0.001$                ---                $< 0.001$                ---                $< 0.001$                ---                 $< 0.001$
    $10{- \mu g/m}^{3}$ increment   0.54 (0.49, 0.59)                $< 0.001$         0.41(0.36, 0.46)          $< 0.001$         0.38 (0.34, 0.43)         $< 0.001$         0.38 (0.33, 0.42)          $< 0.001$

Note: Crude Model: no adjustment; Adjusted Model 1: adjusted by age, sex and education level; Adjusted Model 2: also adjusted by smoking, alcohol use, physical activity, occupational exposure to dust/organic solvents and season; Adjusted Model 3: also adjusted by body mass index, hypertension, diabetes, hyperlipidemia, cardiovascular disease/stroke, and cancer. CI, confidence interval; ${PM}_{2.5}$, particulate matter with aerodynamic diameter $< 2.5\;\mu m$.

The results of the stratified analysis of blood pressure and ${PM}_{2.5}$ are shown in [Figure 2](#f2){ref-type="fig"}. ${PM}_{2.5}$ was associated with significantly higher SBP and PP in all subgroups, whereas stratum-specific estimates varied for associations with DBP. Interactions between ${PM}_{2.5}$ and hypertension were significant for all three outcomes (*p* for interaction $< 0.05$), with stronger positive associations in the hypertensive participants. Effect modification by other factors was not consistent across the three blood pressure parameters.

![Stratified analysis on associations between long-term ${PM}_{2.5}$ exposure ($10{- \mu g/m}^{3}$ increments) and systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) at baseline. Effect estimates (coefficients) are derived from multivariable linear regression analysis, and bars cover 95% confidence intervals. Results were adjusted for age (not in age-stratified analysis), sex (not in sex-stratified analysis), education level (not in education level--stratified analysis), smoking status (not in smoking-stratified analysis), alcohol drinking, leisure-time physical activity, occupational exposure to dust or organic solvents in the workplace, season, body mass index (BMI; not in BMI-stratified analysis), hypertension (not in hypertension-stratified analysis), diabetes (not in diabetes-stratified analysis), hyperlipidemia, and self-reported cardiovascular disease, stroke, or cancer. The lines with hollow circles from left to right represent the participants who were $< 65\; y\,\text{old}$, were males, had a high education level, were nonsmokers, had no hypertension, had no diabetes, and had BMI $< 25{\,{kg}/m}^{2}$, respectively. The lines with solid circles from left to right represent the participants who were $\geq 65\; y\,\text{old}$, were females, had a low education level, were smokers, had hypertension, had diabetes, and had $\text{BMI} \geq 25{\,{kg}/m}^{2}$, respectively. *p*-Values for interaction terms between ${PM}_{2.5}$ (continuous variable) and each potential modifier (dichotomous variable) are presented in the figure.](EHP2466_f2){#f2}

The results for ${PM}_{2.5}$ and incident hypertension are shown in [Table 4](#t4){ref-type="table"}. Participants with higher ${PM}_{2.5}$ levels were associated with an increased risk of developing hypertension. Similar results were observed after adjusting for confounders. Hazard ratios (HRs) from the fully adjusted model (Adjusted Model 3) were 1.10 (95% CI: 1.05, 1.15), 1.16 (95% CI: 1.11, 1.22), and 1.11 (95% CI: 1.06, 1.16) for the participants with ${PM}_{2.5}$ in the second, third, and fourth quartiles, respectively. When ${PM}_{2.5}$ was modeled as a continuous variable, every $10{- \mu g/m}^{3}$ increment was associated with a 3% increase in risk \[$\text{HR} = 1.03$ (95% CI: 1.01, 1.05)\]. Results were similar between strata of age, sex, educational level, smoking, diabetes, and obesity (all *p* for interaction $> 0.05$) ([Figure 3](#f3){ref-type="fig"}).

###### 

Association between long-term exposure to ${PM}_{2.5}$ and incident hypertension in Taiwanese adults.

Table 4 lists PM sub 2.5 (n equals 125,913) in the first column; the corresponding hazard ratios (95 percent confidence intervals) and P values for the crude model, adjusted model 1, adjusted model 2, and adjusted model 3 are listed in the other columns.

  ${PM}_{2.5}$ ($n = 125,913$)                                                                                                                        Crude Model
  ------------------------------- ------------------- ----------- ------------------- ----------- ------------------- ----------- ------------------- -------------
  1st Quartile                    Reference           ---         Reference           ---         Reference           ---         Reference           ---
  2nd Quartile                    1.06 (1.01, 1.10)   0.02        1.10 (1.05, 1.15)   $< 0.001$   1.10 (1.05, 1.14)   $< 0.001$   1.10 (1.05, 1.15)   $< 0.001$
  3rd Quartile                    1.11 (1.06, 1.16)   $< 0.001$   1.18 (1.13, 1.24)   $< 0.001$   1.18 (1.13, 1.24)   $< 0.001$   1.16 (1.11, 1.22)   $< 0.001$
  4th Quartile                    1.16 (1.11, 1.21)   $< 0.001$   1.14 (1.09, 1.19)   $< 0.001$   1.14 (1.09, 1.19)   $< 0.001$   1.11 (1.06, 1.16)   $< 0.001$
  Trend test                      ---                 $< 0.001$   ---                 $< 0.001$   ---                 $< 0.001$   ---                 $< 0.001$
  $10{- \mu g/m}^{3}$ increment   1.06 (1.04, 1.08)   $< 0.001$   1.05 (1.03, 1.07)   $< 0.001$   1.05 (1.03, 1.07)   $< 0.001$   1.03 (1.01, 1.05)   0.001

Note: Crude Model: no adjustment; Adjusted Model 1: adjusted by age, sex and education level; Adjusted Model 2: also adjusted by smoking, alcohol use, physical activity, occupational exposure to dust/organic solvents and season; Adjusted Model 3: also adjusted by body mass index, diabetes, hyperlipidemia, cardiovascular disease/stroke, and cancer. CI, confidence interval; HR, hazard ratio; ${PM}_{2.5}$, particulate matter with aerodynamic diameter $< 2.5\;\mu m$.

![Stratified analysis on associations between long-term ${PM}_{2.5}$ exposure ($10 - \mu g/m^{3}$ increments) and incident hypertension. Effect estimates (hazard ratios) are derived from Cox proportional hazard regression analysis, and bars cover 95% confidence intervals. Results were adjusted for age (not in age-stratified analysis), sex (not in sex-stratified analysis), education level (not in education level--stratified analysis), smoking status (not in smoking-stratified analysis), alcohol drinking, leisure-time physical activity, occupational exposure to dust or organic solvents in the workplace, season, body mass index (BMI; not in BMI-stratified analysis), diabetes (not in diabetes-stratified analysis), hyperlipidemia, and self-reported cardiovascular disease, stroke, or cancer. The lines with hollow circles from left to right represent the participants who were $< 65\; y\,\text{old}$, were males, had a high education level, were nonsmokers, had no diabetes, and had BMI $< 25{\,{kg}/m}^{2}$, respectively. The lines with solid circles from left to right represent the participants who were $\geq 65\; y\,\text{old}$, were females, had a low education level, were smokers, had diabetes, and had $\text{BMI} \geq \, 25{\,{kg}/m}^{2}$, respectively. *p*-Values for interaction terms between ${PM}_{2.5}$ (continuous variable) and each potential modifier (dichotomous variable) are calculated and presented in the figure.](EHP2466_f3){#f3}

The results of the sensitivity analyses are presented in Tables S1 and S2. Exclusion of the participants who used their company address or those with comorbidities did not change the results noticeably (compare Table S1 with [Table 3](#t3){ref-type="table"}). For incident hypertension, results similar to those of the overall cohort were observed among participants with $\geq 2\; y$ of follow-up (compare Table S2 with [Table 4](#t4){ref-type="table"}).

Discussion {#s4}
==========

To the best of our knowledge, this is the largest study to investigate the health effects of long-term exposure to ${PM}_{2.5}$ air pollution on both blood pressure and hypertension development in a same population. We found that the 2-y average ${PM}_{2.5}$ was associated with increased levels of SBP, DBP, and PP. In line with these positive associations with blood pressure, ${PM}_{2.5}$ exposure was associated with an increased risk of incident hypertension. The results remained robust after adjusting for a wide range of confounders and modifiers and in a series of sensitivity analyses. Our results show that every $10{- \mu g/}m^{3}$ increment in ${PM}_{2.5}$ was associated with a 3% higher risk of developing hypertension. The World Health Organization (WHO) estimated that 1 billion adults were hypertensive worldwide in 2008 ([@c34]). Based on the formula for calculating population attributable fraction, $$\frac{\sum\limits_{i = 1}^{n}P_{i}\left( \text{RR}\, - \, 1 \right)}{\sum\limits_{i = 1}^{n}{P_{i}\left( {RR}\, - \, 1 \right) + 1}},$$where $i$ is the level of ${PM}_{2.5}$ in micrograms per cubic meter, $P_{i}$ is the percentage of the population exposed to that level of air pollution, and RR is relative risk ([@c35]), and on the fact that exposure to air pollution is ubiquitous, we estimated that a universal increment of $10{\,\mu g/m}^{3}$ in ${PM}_{2.5}$ may contribute to 29 million hypertensive patients if the effect magnitude of 1.03 is valid globally.

Our findings of a positive association between PM air pollution and blood pressure are in line with some previous studies. Long-term exposure to PM or black carbon, a surrogate for particulate traffic emissions, has been reported to be associated with increases in both SBP and DBP in Taiwan ([@c9]), Germany ([@c16]), China ([@c14]), and the United States ([@c26]). However, the results of some other studies have been inconsistent. Chan et al. ([@c5]) reported positive associations of ${PM}_{2.5}$ exposure with SBP and PP, but not with DBP. The associations for DBP in the present study were also less consistent than those for SBP and PP. Negative associations were observed for the second and third quartiles, and the reasons for this phenomenon are unclear. In contrast, a recent study in Taiwan reported that long-term exposure to PM was associated with increased DBP but not SBP ([@c7]). The European Study of Cohorts for Air Pollution Effects (ESCAPE) project in Europe ([@c17]) did not find a significant association of PM exposure with either SBP or DBP. In the NHANES III study in the United States, neither SBP, DBP, nor PP was associated with long-term exposure to PM with an aerodynamic diameter $< 10\;\mu m$ (${PM}_{10}$) ([@c27]). Two studies in children also showed inconsistent findings ([@c1]; [@c22]). Among 2,368 German children, Liu et al. ([@c22]) reported no consistent associations for exposure to ${PM}_{2.5}$, ${PM}_{10}$, or ${PM}_{2.5}$ absorbance with SBP or DBP. In a Dutch study, long-term exposure to nitrogen dioxide ($\text{NO}_{2}$) and ${PM}_{2.5}$ were positively associated with DBP, but not with SBP, and the observed associations were only statistically significant among children who had lived at the same address since birth ([@c1]).

This inconsistency may be due to a number of factors, including the heterogeneity of the study populations and study regions as well as the research methods. Studies on the relationship between PM and blood pressure, including the present one, are generally of cross-sectional design, which may result in greater uncertainties. The accuracy of the exposure estimates may also play an important role in the inconsistency among the studies. Some of the previous studies ([@c9]; [@c14]; [@c27]) estimated PM exposure based on the proximity of residences to fixed monitoring stations, with the same exposure level assigned to an entire community (district, county, or city). This community-level exposure assessment may have introduced exposure misclassification. For those studies using individual-level exposure, different modeling methods were applied for PM estimates. Dispersion models ([@c16]) and land-use regression models ([@c1]; [@c7]; [@c17]; [@c22]; [@c26]) were the most commonly adopted methods in these studies. One study in the United States also used satellite-based technology; in this study, a positive association was found between 1-y average ${PM}_{2.5}$ and SBP and PP ([@c5]). Furthermore, the sizes of the effects of ${PM}_{2.5}$ on the three blood pressure parameters are very small, and blood pressure may fluctuate because it is easily influenced by a number of factors. The results for the three blood pressure parameters are not as stable as those for incident hypertension in the present study as well.

To date, only four studies have prospectively investigated the associations between long-term ${PM}_{2.5}$ exposure and the incidence of hypertension. The Nurses' Health Study found that every $10{- \mu g/m}^{3}$ increment in ${PM}_{2.5}$ was associated with a 4% increase in the risk of incident hypertension \[$\text{HR} = 1.04$ (95% CI: 1.00, 1.07)\] ([@c39]), which is similar to our findings. A Canadian study with 35,303 adults also reported that long-term exposure to ${PM}_{2.5}$ was positively associated with hypertension incidence, but the effect size was slightly larger \[HR per $10\,\mu g/m^{3}$ ${PM}_{2.5}$ increment, 1.13 (95% CI: 1.05, 1.22)\] ([@c6]). However, the Black Women's Health Study of participants living in Los Angeles found no significant association ([@c10]). The extension of this analysis to the whole study cohort still failed to reveal any significant associations ([@c11]). All of these studies were conducted in North America, and the average ${PM}_{2.5}$ air pollution levels were 10.7 ([@c6]), 13.9 ([@c11]), 15.6 ([@c39]), and $20.7{\,\mu g/m}^{3}$ ([@c10]), respectively, which were lower than the level in our study ($26.5\,{\mu g/m}^{3}$). As for study population, two studies were conducted mainly in Caucasian populations ([@c6]; [@c39]), and the Black Women's Health Study was in African-American women ([@c10]; [@c11]). Thus, it may be difficult to compare them directly with our study. A Danish cohort study investigated the traffic-related pollutant nitrogen oxides ($\text{NO}_{x}$) rather than ${PM}_{2.5}$, but the authors reported no association with incident hypertension ([@c28]).

The biological mechanisms through which PM can raise blood pressure are not fully understood. One plausible pathway is that PM exposure may lead to raised blood pressure by instigating autonomic imbalance ([@c4]). Inhaled PM can stimulate receptors and nerve endings in the airways and thereby alter the reflexes of the autonomic nervous system, leading to a blunting of cardiovascular parasympathetic tone and a relative favoring of sympathetic activity, consequently raising the blood pressure ([@c36]). Another hypothesized pathway is via impaired endothelial function elicited by the chronic systemic inflammation and oxidative stress induced by PM ([@c4]). Our previous study ([@c38]) and others ([@c18]; [@c30]) have reported positive associations between long-term ${PM}_{2.5}$ exposure and markers of systemic inflammation, which partially supports this hypothesis.

In stratified analyses, we found stronger associations between ${PM}_{2.5}$ and blood pressure in the elderly, females, never smokers, and participants with hypertension, diabetes, or normal weight ($\text{BMI} < \, 25.0{\,{kg}/m}^{2}$), although the observed modifying effects were not consistent across the three blood pressure measures, particularly for DBP. There is limited information on these potential modifiers at the present time. A German study reported that ${PM}_{2.5}$ exposure had smaller effects on blood pressure in smokers ([@c16]), which is in line with our results. A study in the United States also found stronger associations between ${PM}_{2.5}$ exposure and carotid intima-media thickness, a measure of atherosclerosis, in nonsmokers ([@c21]). It was hypothesized that smoking and air pollutants may share the same pathways in mediating cardiovascular effects through oxidative stress and inflammation. Smoking may play a dominant role in smokers. Therefore, the additional exposure to air pollutants might not further enhance the effects along the same pathway ([@c21]). Reports on effect modification by obesity have also been inconsistent. Two previous studies ([@c16]; [@c26]) did not find a significant effect modification, which is contrast to our findings. On the other hand, in our analysis on ${PM}_{2.5}$ and incident hypertension, we did not find any significant effect modification. Because blood pressure is easily fluctuant and the present analysis on ${PM}_{2.5}$ and blood pressure is cross-sectional in nature, interpretation regarding modifiers should be made cautiously. Further studies on this issue are warranted.

Our study has some important strengths. We included 361,560 adults in the analysis of the association between PM and blood pressure. Previous studies had sample sizes ranging from 853 to 113,926. For the analysis on the associations between PM and hypertension development, we included 125,913 nonhypertensive adults. The sample sizes of the previous four studies were 3,236 ([@c10]), 35,303 ([@c6]), 33,771 ([@c11]), and 74,800 ([@c39]). The large sample size in the present study enabled us to detect even small effects of ${PM}_{2.5}$ air pollution. We collected a wealth of information on a wide range of potential confounders to better characterize the relationship between ${PM}_{2.5}$ exposure and hypertension. The longitudinal nature of the cohort enabled us to examine the effects of ${PM}_{2.5}$ exposure on hypertension development prospectively. Another strength is the use of a spatiotemporal model with high resolution ($1\;{km} \times 1\;{km}$) to estimate individual exposure based on the participants' addresses. This technology enabled us to overcome the problems with spatial coverage that typically occur when only using data from fixed monitoring stations.

This study also has some limitations. First, we only measured participants' blood pressure once during their visit if their first blood pressure reading was not hypertensive; this is not strictly in accordance with the clinical guidelines, which require multiple measurements. However, a second measurement was obtained if a participant had an SBP $\geq 140\,\text{mmHg}$ or a DBP $\geq 90\,\text{mmHg}$ in the first measurement. The second measurement was intended to minimize "white coat" effects. Another limitation is that information on noise exposure was not available. We cannot exclude the possible confounding effect of noise in this study. However, the wide geographic coverage and the large sample size in our study may have minimized the confounding effects ([@c29]). Finally, the ${PM}_{2.5}$ exposure levels were calculated at fixed addresses, and participants' activity patterns were not taken into account. More advanced technologies are needed for more accurate exposure assessment in future studies.

Conclusion {#s5}
==========

In conclusion, we found that long-term exposure to ${PM}_{2.5}$ air pollution is associated with higher levels of SBP, DBP, and PP after adjusting for a wide range of covariates and possible confounders. In line with the positive associations with blood pressure, long-term exposure to ${PM}_{2.5}$ air pollution is also associated with an increased risk of developing hypertension. Our study provides strong evidence of a role for ${PM}_{2.5}$ exposure in the development of hypertension, a well-established determinant of CVD morbidity and mortality. Our findings support the urgent need to develop global strategies on air pollution mitigation for the prevention of CVD.
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